The trial was stopped prematurely when another trial demonstrated reduced mortality by antifungal prophylaxis with posaconazole, thus rendering further randomisation against placebo unethical.

• 这项试验由于另一项证明预防性泊沙康唑应用可以降低死亡率的试验而提前结束，因为在这种条件下继续进行随机试验对安慰剂组违反了医学伦理。